Las Vegas, NV -- (SBWIRE) -- 10/01/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN), NewLead Holdings Ltd(NASDAQ:NEWL), Sprint Corporation(NYSE:S), Zalicus Inc(NASDAQ:ZLCS)
Achillion Pharmaceuticals, Inc.(NASDAQ:ACHN) ended lower -58.29% and complete the day at $3.02. The total number of shares changed hands during the day was 38.85 million. After opening at $3.44, the stock hit as high as $3.62. However, it traded between $2.87 and $11.36 over the last twelve months. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally.
Has ACHN Found The Bottom and Ready To Move Up? Find Out Here
NewLead Holdings Ltd(NASDAQ:NEWL) closed yesterday at $0.137, a -10.58% decrease. Around 24.31 million shares were traded, beating an-average trading volume of 10.72 million shares. The company is now valued at around $54.36 million. NewLead Holdings Ltd., a shipping and commodity company, is engaged in the transportation of refined products and dry bulk goods worldwide.
Has NEWL Found The Bottom And Ready To Gain Momentum? Find Out Here
Sprint Corporation(NYSE:S) moved +0.96 percent higher at $6.22 and traded between $6.05 and $6.27 after opening the day at $6.0.9. Its performance over the last five days remained -0.65%, which stands at -7.32% for a month. Going back further than one month, 1-year performance after recent close was +12.05%. Sprint Corporation provides wireless and wireline communications services to consumers, businesses, and government users in the United States, Puerto Rico, and the U.S. Virgin Islands.
Will S Continue To Move Higher? Find Out Here
Zalicus Inc(NASDAQ:ZLCS)’s shares rose, gaining +23.71 percent to close at $1.20. The stock is up around +84.62% this year and +62.14% for the last 12 months. Around 16.70 million shares changed hands yesterday, higher from an-average trading volume of 3.00 million shares. Zalicus Inc., a biopharmaceutical company, engages in the discovery and development of novel treatments for patients suffering from pain.
Why Should Investors Buy ZLCS After The Recent Gain? Just Go Here and Find Out
About Value Stock Pick
Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks.
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)